Results 151 to 160 of about 4,861,792 (337)
Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology.
S. Eguchi+3 more
semanticscholar +1 more source
INFUSION OF ANGIOTENSIN-II ANALOGUE IN TWO PATIENTS WITH UNILATERAL RENOVASCULAR HYPERTENSION [PDF]
A. J. M. Donker, Frans H. H. Leenen
openalex +1 more source
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye+19 more
wiley +1 more source
Centrally Mediated Vasopressor Effect of Angiotensin II in Man
Hideo UEDA+4 more
openalex +2 more sources
ABSTRACT Background Despite achieving complete revascularization, patients with coronary artery disease (CAD) may experience adverse outcomes, potentially attributable to coronary microvascular dysfunction (CMD). Coronary flow reserve (CFR), which integrates both epicardial and microvascular coronary function, and a reduced CFR following complete ...
Jingjing Liu+3 more
wiley +1 more source
Evaluation of the Pressor, Cardiac, and Renal Hemodynamic Properties of Angiotensin II in Man
Frank A. Finnerty+3 more
openalex +1 more source
Evaluation of Angiotensin II Metabolism in Sheep by Radioimmunoassay [PDF]
Michael D. Cain+3 more
openalex +1 more source
ABSTRACT Background Mortality in patients with cardiogenic shock (CS) remains high despite advanced treatment strategies in CS patients, underlining the need for the identification of predictors of prognosis in CS patients. Therefore, the present study investigates the prognostic impact of coronary chronic total occlusions (CTO) in patients with CS ...
Michael Behnes+15 more
wiley +1 more source
Acceleration of catecholamine biosynthesis in sympathetically innervated tissues by angiotensin‐II‐amide [PDF]
Margaret C. Boadle‐Biber+2 more
openalex +1 more source